A LinkedIn post from Infinity Bio Inc highlights the company’s presence at IMMUNOLOGY2026 in Boston, where team members are participating in networking, poster, and booth activities. The post notes that scientist Katy Shaw-Saliba, PhD, is involved in both a biotech careers networking session and a scientific poster presentation on large-scale decoding of the antibody reactome using novel antigen display technology.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn content also notes that Jean-Philippe Laine is available at a dedicated booth throughout the day, suggesting an emphasis on direct engagement with researchers, partners, and potential recruits. For investors, this visibility at a major immunology conference may indicate ongoing efforts to showcase Infinity Bio’s platform capabilities, strengthen academic and industry relationships, and support talent acquisition, all of which could be relevant to long-term pipeline development and business development opportunities.